Skip to content

Clinical trials

Completed Hepatoblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatoblastoma Status: Completed Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20081
20091
20115
20151
20174
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Children's Oncology Group5
Emory University3
Children's National Research Institute1
Masonic Cancer Center, University of Minnesota1
Memorial Sloan Kettering Cancer Center1
Novartis Pharmaceuticals1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatoblastoma20
Neuroblastoma17
Osteosarcoma15
Sarcoma13
Rhabdomyosarcoma12
Medulloblastoma11
Wilms Tumor11
Rhabdoid Tumor10
Central Nervous System Neoplasms9
Neuroectodermal Tumors, Primitive, Peripheral9

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.